NCT07090161 Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension Status RECRUITING Phase PHASE2
NCT06961968 Randomized Withdrawal Study in Patients With Schizophrenia Status RECRUITING Phase PHASE3
NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents Status RECRUITING Phase PHASE4
NCT05344365 A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis Status WITHDRAWN Phase PHASE2
NCT04819776 Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Status COMPLETED Phase PHASE3
NCT04712734 A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia Status COMPLETED Phase PHASE1
NCT04127058 Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia Status COMPLETED Phase PHASE1
NCT02600741 Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Status COMPLETED Phase N/A
NCT02453893 Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia Status UNKNOWN Phase PHASE3
NCT01929889 Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia Status TERMINATED Phase PHASE4
NCT01920802 Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo Status COMPLETED Phase PHASE4
NCT01917318 Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD) Status TERMINATED Phase PHASE2
NCT01623713 Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia Status COMPLETED Phase PHASE2
NCT01529294 Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01498770 An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) Status COMPLETED Phase N/A
NCT01464229 Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability Status COMPLETED Phase PHASE4
NCT01207414 Switching to Iloperidone From Other Antipsychotics in Schizophrenia Status COMPLETED Phase PHASE4
NCT00254202 Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia Status COMPLETED Phase PHASE3